Maralixibat 9.5 MG/ML [Livmarli]
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Children's Hospital Los Angeles
Overview
Maralixibat 9.5 MG/ML [Livmarli] is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Maralixibat 9.5 MG/ML [Livmarli] clinical trials
Explore related
Medical disclaimer. This page summarizes research about Maralixibat 9.5 MG/ML [Livmarli] for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.